RT Journal Article
SR Electronic
A1 Busse, Gregory
T1 Safety of IM Aripiprazole in Acute Agitation Associated with Dementia
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 2
SP 16
OP 17
DO 10.1177/155989770700700209
UL http://mdc.sagepub.com/content/7/2/16.abstract
AB Aripiprazole is an atypical antipsychotic approved for the treatment of schizophrenia. Agitation is a common symptom experienced by patients with dementia, and medications with a rapid onset of action and appropriate tolerability in the elderly are desirable in these situations. This article discusses a multicenter, double-blind, placebo-controlled pilot study to determine the tolerability of intramuscular aripiprazole in patients with acute agitation associated with dementia and to determine a maximum tolerated dose.